SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-09
👔
Evommune, Inc.
@EVMN_InsiderForm 4 Filing: KIRSCH ARTHUR S Buys $133,000 of $EVMN
INSIDER PURCHASE
⚡ MATERIALITY: 6/10
corporate issuer
Evommune, Inc.
Ticker: $EVMN
Transaction Value
$133,000
Price/Share: $13.30
transaction date
2026-07-07
Shares: 10,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, KIRSCH ARTHUR S, holds the title of Director at Evommune, Inc..
On 2026-07-07, the insider transacted 10,000 shares.The shares were transacted at a weighted average price of $13.30 per share, resulting in a total market-relevant value of $133,000.
Executive Summary Summary
KIRSCH ARTHUR S (Director) bought $133K of $EVMN
Post-Transaction Position: 10,000 shares
SEC Accession No: 0001290976-26-000004 (CIK: 1290976)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.